SCHEMBL3793566

SCHEMBL3793566

NC(=O)c1ccc(-c2ccccc2)cc1N

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 5/20 0.73
KDM4E B2RXH2 2/20 0.55
KMT2A Q03164 2/20 0.55
MEN1 O00255 1/20 0.55
USP2 O75604 1/20 0.55
ALDH1A1 P00352 1/20 0.55
LMNA P02545 1/20 0.55
HSP90AA1 P07900 1/20 0.55
GAA P10253 1/20 0.55
MAPT P10636 1/20 0.55
HPGD P15428 1/20 0.55
ALOX15 P16050 1/20 0.55
ALOX12 P18054 1/20 0.55
HTT P42858 1/20 0.55
HSD17B10 Q99714 1/20 0.55
PPM1B O75688 1/20 0.54
HNF4A P41235 2/20 0.52
ACMSD Q8TDX5 2/20 0.52
BCAT2 O15382 1/20 0.50
SIRT2 Q8IXJ6 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2575452 0.86 PPM1B (0.71) IKBKBKDM4EKMT2AMEN1USP2
SCHEMBL30456877 0.86 PPM1B (0.71) IKBKBKDM4EKMT2AMEN1USP2
SCHEMBL3781502 0.86 IKBKB (0.55) IKBKBKDM4EKMT2AMEN1USP2
SCHEMBL3784526 0.85 IKBKB (0.54) IKBKBMEN1PPM1BMCL1MKNK2
SCHEMBL28033110 0.85 PPM1B (0.54) IKBKBKDM4EKMT2AMEN1USP2
SCHEMBL3781950 0.85 IKBKB (1.00) IKBKBKDM4EKMT2AMEN1USP2
SCHEMBL5332435 0.84 IKBKB (0.72) IKBKBHNF4AACMSDBCAT2SIRT2
SCHEMBL30595681 0.84 IKBKB (0.72) IKBKBHNF4AACMSDBCAT2SIRT2
SCHEMBL3789666 0.83 IKBKB (0.56) IKBKBKDM4EKMT2AMEN1USP2
SCHEMBL14392234 0.83 IKBKB (0.56) IKBKBKDM4EKMT2AMEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 IKBKB 2611/4885KDM4E 2606/4885KMT2A 1474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.